Bavarian Nordic to discontinue RSV vaccine programme
July 22 (Reuters) – Denmark-based Bavarian Nordic (BAVA.CO) said on Saturday it was ending its respiratory syncytial virus (RSV) vaccine programme as its Phase 3 clinical trial did not meet … Read More